TP-434 is a fully synthetic tetracycline designed for troublesome hospital pathogens

被引：0
|
作者：
Sutcliffe, Joyce [1 ]
机构：
[1] Tetraphase Pharmaceut Inc, Biol, Watertown, MA 02472 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 244卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
693-ORGN
引用
收藏
页数：1
相关论文
共 2 条
  • [1] Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
    Sutcliffe, J. A.
    O'Brien, W.
    Fyfe, C.
    Grossman, T. H.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (11) : 5548 - 5558
  • [2] Process Development and Scale-up of Fully Synthetic Tetracycline TP-2758: A Potent Antibacterial Agent with Excellent Oral Bioavailability
    Zhang, Wu-Yan
    Sun, Cuixiang
    Hunt, Diana
    He, Minsheng
    Deng, Yonghong
    Zhu, Zhijian
    Chen, Chi-Li
    Katz, Christopher E.
    Niu, John
    Hogan, Philip C.
    Xiao, Xiao-Yi
    Dunwoody, Nicholas
    Ronn, Magnus
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2016, 20 (02) : 284 - 296
1